Zheng Xing Xing Ye Ri Bao·2025-12-26 09:07Core Viewpoint - The biopharmaceutical sector experienced a slight decline of 0.02% on December 26, with Jindike leading the drop, while the Shanghai Composite Index rose by 0.1% and the Shenzhen Component Index increased by 0.54% [1] Group 1: Market Performance - The closing prices and performance of key biopharmaceutical stocks showed mixed results, with Heyi Biotech rising by 3.17% to 71.61 and Jindike falling by 2.54% to 21.88 [1][2] - The trading volume for Heyi Biotech was 33,900 shares, with a transaction value of 239 million yuan, while Jindike had a trading volume of 38,900 shares and a transaction value of 85.44 million yuan [1][2] Group 2: Capital Flow - The biopharmaceutical sector saw a net outflow of 185 million yuan from institutional investors, while retail investors had a net inflow of 142 million yuan [2] - Key stocks like Gann Li Pharmaceutical had a net inflow of 13.59 million yuan from institutional investors, but a net outflow of 24.81 million yuan from retail investors [3]